Cargando…

A Study of Anxiety and Depression in Benign Breast Disease

BACKGROUND: To compare the prevalence of anxiety and depression levels in patients with benign breast disease (BBD) and healthy individuals using Hospital Anxiety and Depression Scale (HADS) and Brief Patient Health Questionnaire (BPHQ). METHODS: This study includes 100 patients who were clinically...

Descripción completa

Detalles Bibliográficos
Autores principales: Srivastava, Vivek, Meena, Rakesh Kumar, Ansari, Mumtaz A., Kumar, Dheeraj, Kumar, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978053/
https://www.ncbi.nlm.nih.gov/pubmed/33767560
http://dx.doi.org/10.4103/jmh.JMH_85_20
_version_ 1783667148206374912
author Srivastava, Vivek
Meena, Rakesh Kumar
Ansari, Mumtaz A.
Kumar, Dheeraj
Kumar, Anand
author_facet Srivastava, Vivek
Meena, Rakesh Kumar
Ansari, Mumtaz A.
Kumar, Dheeraj
Kumar, Anand
author_sort Srivastava, Vivek
collection PubMed
description BACKGROUND: To compare the prevalence of anxiety and depression levels in patients with benign breast disease (BBD) and healthy individuals using Hospital Anxiety and Depression Scale (HADS) and Brief Patient Health Questionnaire (BPHQ). METHODS: This study includes 100 patients who were clinically suspected of having BBDs and were matched against 100 healthy age-matched controls from June 2016 and July 2018. The diagnosis of BBD was established on the basis of ultrasonography, fine needle aspiration cytology, and/or histopathology. For the diagnosis of anxiety and depression, BPHQ was used and the level of anxiety and depression was measured using the HADS. The questionnaire at both prediagnosis and at follow-up assessment after 3 months was done. RESULTS: On comparing anxiety and depression using BPHQ score among cases and controls, both were significantly associated with cases than controls (P < 0.001 and P = 0.0016, respectively). On comparing anxiety and depression using HADS score, there was a significant difference (median) in both anxiety and depression level between cases and controls (P < 0.001 and P < 0.001, respectively). After 3 months of follow-up, there was a significant improvement in anxiety and depression scores by both BPHQ (P = 0.007 and P = 0.0016) and HADS (P < 0.001 and P < 0.001). The 3-month follow-up data showed a significant improvement in BPHQ (depression) score in patients with breast lump and mastalgia (P = 0.001 and P = 0.008). The HADS (anxiety score) showed significant improvement in patients presenting with diseases/aberrations other than fibroadenoma while the HADS (depression) score showed a significant improvement in all except fibroadenosis present either alone or along with fibroadenoma. The HADS (depression) score showed a significant improvement in fibroadenoma, others group, breast lump, and mastalgia (P = 0.040, P = 0.005, P < 0.001, and P = 0.025, respectively). CONCLUSION: Indian female patients who present with BBDs are also affected by anxiety and depression.
format Online
Article
Text
id pubmed-7978053
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-79780532021-03-24 A Study of Anxiety and Depression in Benign Breast Disease Srivastava, Vivek Meena, Rakesh Kumar Ansari, Mumtaz A. Kumar, Dheeraj Kumar, Anand J Midlife Health Original Article BACKGROUND: To compare the prevalence of anxiety and depression levels in patients with benign breast disease (BBD) and healthy individuals using Hospital Anxiety and Depression Scale (HADS) and Brief Patient Health Questionnaire (BPHQ). METHODS: This study includes 100 patients who were clinically suspected of having BBDs and were matched against 100 healthy age-matched controls from June 2016 and July 2018. The diagnosis of BBD was established on the basis of ultrasonography, fine needle aspiration cytology, and/or histopathology. For the diagnosis of anxiety and depression, BPHQ was used and the level of anxiety and depression was measured using the HADS. The questionnaire at both prediagnosis and at follow-up assessment after 3 months was done. RESULTS: On comparing anxiety and depression using BPHQ score among cases and controls, both were significantly associated with cases than controls (P < 0.001 and P = 0.0016, respectively). On comparing anxiety and depression using HADS score, there was a significant difference (median) in both anxiety and depression level between cases and controls (P < 0.001 and P < 0.001, respectively). After 3 months of follow-up, there was a significant improvement in anxiety and depression scores by both BPHQ (P = 0.007 and P = 0.0016) and HADS (P < 0.001 and P < 0.001). The 3-month follow-up data showed a significant improvement in BPHQ (depression) score in patients with breast lump and mastalgia (P = 0.001 and P = 0.008). The HADS (anxiety score) showed significant improvement in patients presenting with diseases/aberrations other than fibroadenoma while the HADS (depression) score showed a significant improvement in all except fibroadenosis present either alone or along with fibroadenoma. The HADS (depression) score showed a significant improvement in fibroadenoma, others group, breast lump, and mastalgia (P = 0.040, P = 0.005, P < 0.001, and P = 0.025, respectively). CONCLUSION: Indian female patients who present with BBDs are also affected by anxiety and depression. Wolters Kluwer - Medknow 2020 2021-01-21 /pmc/articles/PMC7978053/ /pubmed/33767560 http://dx.doi.org/10.4103/jmh.JMH_85_20 Text en Copyright: © 2021 Journal of Mid-life Health http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Srivastava, Vivek
Meena, Rakesh Kumar
Ansari, Mumtaz A.
Kumar, Dheeraj
Kumar, Anand
A Study of Anxiety and Depression in Benign Breast Disease
title A Study of Anxiety and Depression in Benign Breast Disease
title_full A Study of Anxiety and Depression in Benign Breast Disease
title_fullStr A Study of Anxiety and Depression in Benign Breast Disease
title_full_unstemmed A Study of Anxiety and Depression in Benign Breast Disease
title_short A Study of Anxiety and Depression in Benign Breast Disease
title_sort study of anxiety and depression in benign breast disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978053/
https://www.ncbi.nlm.nih.gov/pubmed/33767560
http://dx.doi.org/10.4103/jmh.JMH_85_20
work_keys_str_mv AT srivastavavivek astudyofanxietyanddepressioninbenignbreastdisease
AT meenarakeshkumar astudyofanxietyanddepressioninbenignbreastdisease
AT ansarimumtaza astudyofanxietyanddepressioninbenignbreastdisease
AT kumardheeraj astudyofanxietyanddepressioninbenignbreastdisease
AT kumaranand astudyofanxietyanddepressioninbenignbreastdisease
AT srivastavavivek studyofanxietyanddepressioninbenignbreastdisease
AT meenarakeshkumar studyofanxietyanddepressioninbenignbreastdisease
AT ansarimumtaza studyofanxietyanddepressioninbenignbreastdisease
AT kumardheeraj studyofanxietyanddepressioninbenignbreastdisease
AT kumaranand studyofanxietyanddepressioninbenignbreastdisease